These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 1783533)
1. A double blind randomized pilot trial of naloxone in the treatment of acute ischemic stroke. Federico F; Lucivero V; Lamberti P; Fiore A; Conte C Ital J Neurol Sci; 1991 Dec; 12(6):557-63. PubMed ID: 1783533 [TBL] [Abstract][Full Text] [Related]
2. High-dose intravenous naloxone for the treatment of acute ischemic stroke. Olinger CP; Adams HP; Brott TG; Biller J; Barsan WG; Toffol GJ; Eberle RW; Marler JR Stroke; 1990 May; 21(5):721-5. PubMed ID: 2339451 [TBL] [Abstract][Full Text] [Related]
3. Effect of naloxone on acute stroke. Czlonkowska A; Cyrta B Pharmacopsychiatry; 1988 Mar; 21(2):98-100. PubMed ID: 3293092 [TBL] [Abstract][Full Text] [Related]
4. Remacemide hydrochloride: a double-blind, placebo-controlled, safety and tolerability study in patients with acute ischemic stroke. Dyker AG; Lees KR Stroke; 1999 Sep; 30(9):1796-801. PubMed ID: 10471426 [TBL] [Abstract][Full Text] [Related]
5. A double blind trial of naloxone in the treatment of acute stroke. Fallis RJ; Fisher M; Lobo RA Stroke; 1984; 15(4):627-9. PubMed ID: 6087500 [TBL] [Abstract][Full Text] [Related]
6. Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Lubeluzole International Study Group. Diener HC; Hacke W; Hennerici M; Rådberg J; Hantson L; De Keyser J Stroke; 1996 Jan; 27(1):76-81. PubMed ID: 8553408 [TBL] [Abstract][Full Text] [Related]
7. A dose-escalation study of large doses of naloxone for treatment of patients with acute cerebral ischemia. Adams HP; Olinger CP; Barsan WG; Butler MJ; Graff-Radford NR; Brott TG; Biller J; Damasio H; Tomsick T; Goldberg M Stroke; 1986; 17(3):404-9. PubMed ID: 3715936 [TBL] [Abstract][Full Text] [Related]
8. Treatment of acute ischemic stroke with piracetam. Members of the Piracetam in Acute Stroke Study (PASS) Group. De Deyn PP; Reuck JD; Deberdt W; Vlietinck R; Orgogozo JM Stroke; 1997 Dec; 28(12):2347-52. PubMed ID: 9412612 [TBL] [Abstract][Full Text] [Related]
9. Lubeluzole treatment of acute ischemic stroke. The US and Canadian Lubeluzole Ischemic Stroke Study Group. Grotta J Stroke; 1997 Dec; 28(12):2338-46. PubMed ID: 9412611 [TBL] [Abstract][Full Text] [Related]
10. Treatment of experimental stroke with opiate antagonists. Effects on neurological function, infarct size, and survival. Baskin DS; Hosobuchi Y; Grevel JC J Neurosurg; 1986 Jan; 64(1):99-103. PubMed ID: 3941353 [TBL] [Abstract][Full Text] [Related]
17. Reversal of neurological deficits by opiate antagonist naloxone after cerebral ischemia in animals and humans. Hosobuchi Y; Baskin DS; Woo SK J Cereb Blood Flow Metab; 1982; 2 Suppl 1():S98-100. PubMed ID: 7085809 [TBL] [Abstract][Full Text] [Related]
18. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384 [TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, tolerability, and pharmacokinetic/pharmacodynamic effects of a targeted exposure of intravenous repinotan in patients with acute ischemic stroke: modified Randomized Exposure Controlled Trial (mRECT). Teal P; Davis S; Hacke W; Kaste M; Lyden PD; ; Fierus M; Stroke; 2009 Nov; 40(11):3518-25. PubMed ID: 19745176 [TBL] [Abstract][Full Text] [Related]
20. Treatment of experimental stroke: comparison of naloxone and thyrotropin releasing hormone. Faden AI; Hallenbeck JM; Brown CQ Neurology; 1982 Oct; 32(10):1083-7. PubMed ID: 6811967 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]